Difference between revisions of "Team:NJU-China"
| Line 182: | Line 182: | ||
<div class="down" style="opacity: 1"> | <div class="down" style="opacity: 1"> | ||
<p class="learnmore">Learn more about us!</p> | <p class="learnmore">Learn more about us!</p> | ||
| − | <img src=" | + | <img src="https://static.igem.org/mediawiki/2018/0/04/T--NJU-China--down.png" class="downimg" alt="downarrow"> |
</div> | </div> | ||
</div> | </div> | ||
| Line 268: | Line 268: | ||
<!--ner-back start--> | <!--ner-back start--> | ||
<div id="ner-back" class="ner-back-up"> | <div id="ner-back" class="ner-back-up"> | ||
| − | <img id="ner-back-img" class="ner-back-img"src=" | + | <img id="ner-back-img" class="ner-back-img"src="https://static.igem.org/mediawiki/2018/1/17/T--NJU-China--ner-back.png" alt="ner-back" onclick="returnTop()"> |
</div> | </div> | ||
<script type="text/javascript"> | <script type="text/javascript"> | ||
Revision as of 06:05, 23 June 2018
New Strategy for Treating
Fragile X Syndrome
by Targeting Expression of
FMRP Using TBEV5'-UTR
———— NJU-CHINA
Learn more about us!
We (NJU-China 2018 team) aim to find the possible therapy of the Fragile X Syndrome, a genetical disease causing a great number of ill of brain. As is previously analyzed, the syndrome is due to the reduction of a specific protein named FMR-1 in the dendrites of our neural cells. In order to innovate the treatment, we developed a strategy by using a designed sequence of mRNA to transfer the target gene specially into the dendrites for higher efficiency and accuracy. With the production of the certain sequence, we are able to maintain the production of certain protein in the neuron to the required level.